The impact of molecular targets in cancer drug development: major hurdles and future strategies
出版年份 2012 全文链接
标题
The impact of molecular targets in cancer drug development: major hurdles and future strategies
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 6, Issue 1, Pages 23-34
出版商
Informa UK Limited
发表日期
2012-12-31
DOI
10.1586/ecp.12.71
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
- (2012) Jaap Verweij et al. Molecular Oncology
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Industry perspectives on personalized medicine
- (2012) Rachael Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- 2011 FDA drug approvals
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical trials for predictive medicine
- (2012) Richard Simon STATISTICS IN MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer
- (2011) Massimo Di Maio EXPERT OPINION ON BIOLOGICAL THERAPY
- Aptamers for allosteric regulation
- (2011) Jan L Vinkenborg et al. Nature Chemical Biology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in the preclinical testing of cancer therapeutic hypotheses
- (2011) Giordano Caponigro et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical trials for predictive medicine: new challenges and paradigms
- (2010) Richard Simon Clinical Trials
- Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
- (2010) P. Valent CURRENT CANCER DRUG TARGETS
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Anticancer drug development: the grand challenges
- (2010) William N. Hait NATURE REVIEWS DRUG DISCOVERY
- Targeted cancer therapies
- (2010) Saurabh Aggarwal NATURE REVIEWS DRUG DISCOVERY
- Impact of molecular targets in cancer drug development: historical influence and future perspectives
- (2010) Edgar Selzer Expert Review of Clinical Pharmacology
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
- (2009) T. Fojo et al. JNCI-Journal of the National Cancer Institute
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Imatinib and beyond—exploring the full potential of targeted therapy for CML
- (2009) Alfonso Quintás-Cardama et al. Nature Reviews Clinical Oncology
- The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding
- (2009) A. Bakan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Update on Anti-EGFR Targeted Therapy
- (2009) Daniel Chua et al. Journal of Oncology
- Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
- (2008) Jeffrey Peppercorn et al. CANCER INVESTIGATION
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Protein crystallization: from purified protein to diffraction-quality crystal
- (2008) Naomi E Chayen et al. NATURE METHODS
- Leader of the pack: gene mapping in dogs and other model organisms
- (2008) Elinor K. Karlsson et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now